Mark Hamilton, Assistant Professor in the Department of Lymphoma and Myeloma at The University of Texas MD Anderson Cancer Center, shared on LinkedIn:
“A little late but happy to see our paper in Nature Genetics. This study was a labor of love that I worked on for nearly six years during my post-doc at Stanford.
I hope the paper is helpful to the understanding of CAR-T cell therapy complications for the community.Ultimately this paper was a great learning experience for me as a scientist, where I painstakingly learned many clinical and molecular methods that serve as my foundation as a PI today.
Title: Clonal Hematopoiesis and Cytopenias Following CAR19 Therapy
Authors: Mark P. Hamilton, Nick Phillips, Troy Noordenbos, Jan Boegeholz, Takeshi Sugio, Brian J. Sworder, Stefan K. Alig, Zinaida Good, Joseph G. Schroers-Martin, John Tamaresis, Mohammad S. Esfahani, Ying Lu, Mari Olsen, Chih Long Liu, Zach Ehlinger, Moksha Desai, Lori Muffly, Robert S. Negrin, Sally Arai, Laura Johnston, Robert Lowsky, Everett Meyer, Andrew Rezvani, Judith Shizuru, Wen-Kai Weng, Parveen Shiraz, Surbhi Sidana, Sushma Bharadwaj, Melody Smith, Saurabh Dahiya, Bita Sahaf, Matthew J. Frank, Crystal L. Mackall, Maximilian Diehn, David M. Kurtz, David B. Miklos, Ash A. Alizadeh.
